Yahoo Finance’s Daniel Howley joins the Live show to discuss the battle for market share in the chip space amid declining chip demand. Read More...
Barrons.com
AbbVie Stock Falls as Humira Sales Drop
AbbVie shares took a tumble Thursday after the biopharmaceutical company said first-quarter sales of its anti-inflammatory drug Humira declined from a year ago. AbbVie (ticker: ABBV) posted first-quarter net revenue of $12.23 billion, beating analysts’ expectations for $12.17 billion, but lower than the $13.54 billion recorded a year ago, according to FactSet. Revenue in AbbVie’s immunology, hematologic oncology, aesthetics, and eye care segments declined from a year ago, while revenue for its neuroscience and “other key products” categories rose.
Add Comment